Adult Vaccination and Voluntary Vaccination State of Adults: a Study from Turkey


In this study, establishing the knowledge about adult vaccination and voluntary vaccination state of adults in the prov-ince centre of Kayseri was aimed. This descriptive study was performed in 2009 May-July, in 6 public health centres (PHC) in the province centre of Kayseri, by way of a questionnaire. 998 adults from the population of an area covered by 34 family practitioners, working under six public health care centres, in the province centre of Kayseri, were asked to fill a questionnaire. Chi-square test was used in the statistical analysis and p < 0.05 was accepted as significant. The mean age of the participants was 37.4 ± 14.1 and 56.7% were female. 75.8% of the individuals knew that adults had to be vaccinated and 55.3% that influenza vaccination had to be done every year. 97.9% of the participants were aware of influenza vaccinLation, and the rate of vaccination was 7.8%, 97.8% knew tetanus vaccination, the awareness rate of hepatitis B vaccination was 84.4%, and vaccination rate 25.6%, Human Papilloma Virus (HPV) was known by 44.4%, vaccination rate in women was 1.1%, pneumococcus vaccination was known by 19.8% and vaccination rate was 0.4%. 22.0% of the individuals 65 years old and above had got an influenza vaccination while non-had got a pneumococcus vaccination. It is found that the tetanus, influenza, and hepatitis vaccinations were highly known, whereas, HPV and pneumococcus vaccinations were not, and that the number of individuals stating that they had been vaccinated was quite low.

Share and Cite:

M. Naçar, F. Çetinkaya, Z. Baykan, S. Poyrazoğlu and O. Günay, "Adult Vaccination and Voluntary Vaccination State of Adults: a Study from Turkey," World Journal of Vaccines, Vol. 1 No. 2, 2011, pp. 23-28. doi: 10.4236/wjv.2011.12005.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] L. K. Pickering, C. J. Baker, G. L. Freed, S. A. Gall, S. E. Grogg, G. A. Poland, et al., “Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America,” Clinical Infectious Diseases, Vol. 49, No. 6, 2009, pp. 817-840. doi:10.1086/605430
[2] E. Uskun, S. B. Uskun, M. Uysalgenc and M. Yagiz, “Effectiveness of a Training Intervention on Immunization to Increase Knowledge of Primary Healthcare Workers and Vaccination Coverage Rates,” Public Health, Vol. 122, No. 9, September 2008, pp. 949-958. doi:10.1016/j.puhe.2007.10.005
[3] P. Scognamiglio, E. Girardi, M. Fusco, P. Piselli, S. R. Spena, C. Maione, et al., “Lack of Implementation of Hepatitis B Virus (HBV) Vaccination Policy in Household Contacts of HBV Carriers in Italy,” BMC Infectious Diseases, Vol. 9, 2009, p. 86. doi:10.1186/1471-2334-9-86
[4] P. R. Blank, A. U. Freiburghaus, M. M. Schwenkglenks, T. D. Szucs and U. Kunze, “Influenza Vaccination Coverage Rates in Austria in 2006/07—A Representative Cross-Sectional Telephone Survey,” WMW Wiener Medizinische Wochenschrift, Vol. 158, No. 19-20, 2008, pp. 583-588. doi:10.1007/s10354-008-0582-3
[5] R. M. Merrill and J. D. Beard, “Influenza Vaccination in the United States, 2005-2007,” Med Sci Monit, Vol. 15, No. 7, 2009, pp. 92-100.
[6] V. J. Babb and J. Babb, “Pharmacist Involvement in Healthy People 2010,” Journal of the American Pharmaceutical Association, Vol. 43, No. 1, 2003, pp. 56-60. doi:10.1331/10865800360467051
[7] Turkish Society for Infectious Diseases and Clinical Microbiology Specialty, “Adult Immunization Guide Book,” Turkish Ministry of Health, Ankara, 2009.
[8] R. K. Zimmerman, D. B. Middleton, I. T. Burns, R. D. Clover and S. R. Kimmel, “Routine Vaccines across the Life Span, 2007,” J Fam Pract, Vol. 56 (2 Suppl Vaccines), 2007, S18-37, C1-3.
[9] K. P. High, “Overcoming Barriers to Adult Immunization,” Journal of American Osteopathic Association, Vol. 109, No. 6, 2009, pp. 25-28.
[10] D. R. Johnson, K. L. Nichol and K. Lipczynski, “Barriers to Adult Immunization,” The American Journal of Medicine, Vol. 121, No. 7, July 2008, pp. 28-35. doi:10.1016/j.amjmed.2008.05.005
[11] S. Kala?a, M. Yal?in and S. Sim?ek Yavuz, “Missed Opportunities for Tetanus Vaccination in Pregnant Women, and Factors Associated with Seropositivity,” Public Health, Vol. 118, No. 5, July 2004, pp. 377-382. doi:10.1016/j.puhe.2003.12.011
[12] R. M. Andrews, M. L. Counahan, G. G. Hogg and P. B. McIntyre, “Effectiveness of a Publicly Funded Pneumococcal Vaccination Program against Invasive Pneumococcal Disease among the Elderly in Victoria, Australia,” Vaccine, Vol. 23, No. 2, November 2004, pp. 132-138. doi:10.1016/j.vaccine.2004.06.016
[13] P. Dursun, B. Altuntas, E. Kuscu and A. Ayhan, “Women’s Knowledge about Human Papillomavirus and Their Acceptance of HPV Vaccine,” Australian and New Zealand Journal of Obstetrics and Gynaecology, Vol. 49, No. 2, April 2009, pp. 202-206. doi:10.1111/j.1479-828X.2009.00947.x
[14] F. ?etinkaya, M. Na?ar and Y. ?ztürk, “The Knowledge of Adult Women about Hepatitis B and Vaccination against Hepatitis B Virus,” Journal of Viral Hepatitis, Vol. 1, 1999, pp. 22-27.
[15] P. V. Targonski and G. A. Poland, “Pneumococcal Vaccination in Adults: Recommendations, Trends, and Prospects,” Cleveland Clinic Journal of Medicine, Vol. 74, No. 6, 2007, pp. 401-406. doi:10.3949/ccjm.74.6.401
[16] Y. Zeybek, Y. Tokalak and S. Boyac?o?lu, “Vaccination in the Sixty-Five and over Age Adults,” Turkish Journal of Geriatrics, Vol. 7, No. 3, 2004, pp. 152-154.
[17] H. A. Tu, H. J. Woerdenbag, S. Kane, A. Riewpaiboon, M. Van Hulst and M. J. Postma, “Economic Evaluations of Hepatitis B Vaccination for Developing Countries,” Expert Review of Vaccines, Vol. 8, No. 7, July 2009, pp. 907-920. doi:10.1586/erv.09.53
[18] N. ?ahin, D. Bilgi?, ü. Esen, R. ?etinkaya and Z. Tozo?lu, “Determining Knowledge and Practices of Hairdressers and Manicurist-Pedicurist about Hepatitis B,” TAF Prev Med Bull, Vol. 8, 2009, pp. 147-154.
[19] G. X. Ma, S. E. Shive, J. I. Toubbeh, Y. Tan and D. Wu, “Knowledge, Attitudes, and Behaviors of Chinese Hepatitis B Screening and Vaccination,” American Journal of Health Behavior, Vol. 32, No. 2, April 2008, pp. 178-187.
[20] A. E. Fiore, D. K. Shay, K. Broder, J. K. Iskander, T. M. Uyeki, G. Mootrey, et al., “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009,” MMWR Recommendation Report, Vol. 58(RR-8), 2009, pp. 1-52.
[21] S. Oncel, O. Turhan, P. H. Huseyin and A. N. Yalcin, “Status of Influenza Vaccination in Patients Presenting to Two Neighbourhood Primary Health Care Clinics in Antalya,” Infez Med, Vol. 16, No. 2, June 2008, pp. 74-79.
[22] O. Erg?nül, T. S?zen and E. Tekeli, “Immunity to Tetanus among Adults in Turkey,” Scandinavian Journal of Infectious Diseases, Vol. 33, No. 10, 2001, pp. 728-730. doi:10.1080/003655401317074491
[23] A. ?ztürk, S. G?kahmeto?lu, F. Erdem and S. Misgüro?lu Alkan, “Tetanus Antitoxin Levels among Adults over 40 Years of Age in Central Anatolia, Turkey,” Clinical Microbiology and Infection, Vol. 9, No. 1, January 2003, pp. 33-38. doi:10.1046/j.1469-0691.2003.00469.x
[24] W. Popp, U. Werfel and D. Hansen, “Vaccinations for Adults: Do You Also Ask about Individual Risks?” MMW Fortschr Med, Vol. 151, No. 14, 2009, pp. 23-26.
[25] “Maternal Immunization against Tetanus,” 2009
[26] M. ?nde, F. Ergin, G. Atasoylu and A. ?ubuk, “Missed Opportunities for Tetanus Immunization of 15-49 Year Old Women in Ayd?n,” Journal of Adnan Menderes University Medical Faculty, Vol. 8, No. 1, 2007, pp. 12-18.
[27] A. B. Moscicki, “HPV Vaccines: Today and in the Future,” Journal of Adolescent Health, Vol. 43, No. 4, October 2008, pp. S26-S40. doi:10.1016/j.jadohealth.2008.07.010
[28] H. Marshall, P. Ryan, D. Roberton, P. Baghurst, “A Cross-Sectional Survey to Assess Community Attitudes to Introduction of Human Papillomavirus Vaccine,” Australian and New Zealand Journal of Public Health, Vol. 31, No. 3, June 2007, pp. 235-242. doi:10.1111/j.1467-842X.2007.00054.x
[29] M. Pitts, A. Smith, S. Croy, A. Lyons, R. Ryall and S. Garland, et al., “Singaporean Men’s Knowledge of Cervical Cancer and Human Papillomavirus (HPV) and Their Attitudes towards HPV Vaccination,” Vaccine, Vol. 27, Ni, 22, May 2009, pp. 2989-2993. doi:10.1016/j.vaccine.2009.02.101
[30] E. Uzun, Z. F. Ak?am, E. Zengin, A. N. Ki?io?lu and G. S. Yayl?, “Evaluation of the Hepatitis B infection status, knowledge and behaviours of the research assistants of Suleyman Demirel University School of Medicine,” Journal of Suleyman Demirel University Medical Faculty, Vol. 15, 2008, pp. 22-27.
[31] D. Zamir, C. Zamir and S. Rishpon, “Epidemiology of Hepatitis B Virus Infection among Family Members of Chronic Carriers in Israel,” Israel Medical Association Journal, Vol. 3, 2001, pp. 338-340.
[32] G. D. Zimet, R. M. Mays, Y. Winston, R. Kee, J. Dickes and L. Su, “Acceptability of Human Papillomavirus Immunization,” Womens Health Gend Based Med, Vol. 9, No. 1, July 2000, pp. 47-50. doi:10.1089/152460900318957
[33] E. ?nal, S. ?zel, S. Erbil and ?. Ayvaz, “Knowledge Level of 4th and 6th Grade Medical School Students about Adult Tetanus and Diphtheria Vaccines,” Nobel Medicus, Vol. 4, 2008, pp. 27-31.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.